Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary

por Lontai, Livia, Kürti, Zsuzsanna, Gonczi, Lorant, Komlódi, Nóra, Balogh, Fruzsina, Iliás, Ákos, Lakatos, Peter L.
Publicado 2023

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance F...

por Kurti, Zsuzsanna, Ilias, Akos, Gonczi, Lorant, Vegh, Zsuzsanna, Fadgyas-Freyler, Petra, Korponay, Gyula, Golovics, Petra A., Lovasz, Barbara D., Lakatos, Peter L.
Publicado 2018

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a mul...

por Bacsur, Péter, Matuz, Mária, Resál, Tamás, Miheller, Pál, Szamosi, Tamás, Schäfer, Eszter, Sarlós, Patrícia, Iliás, Ákos, Szántó, Kata, Rutka, Mariann, Bálint, Anita, Milassin, Ágnes, Fábián, Anna, Bor, Renáta, Szepes, Zoltán, Molnár, Tamás, Farkas, Klaudia
Publicado 2022